Janani Rangaswami, MDClinical Associate ProfessorEinstein Medical Center / Thomas Jefferson UniversityDepartment of Medicine / NephrologyPhiladelphia, PA, USA  Edgar V. Lerma, MDClinical Professor of MedicineUIC/Advocate Christ Medical CenterDepartment of MedicineOak Lawn, IL, USA Peter A. McCullough, MD, MPHConsultant Cardiologists and Vice Chief of Internal MedicineBaylor University Medical CenterBaylor Heart and Vascular HospitalDepartment of Internal MedicineTexas A & M College of MedicineDivision of CardiologyDallas, TX, USA

• Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes.- Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions.- Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies.- Cardiovascular impact of Atherosclerotic Renovascular Disease.- Platelet Function testing and antiplatelet agent choice in CKD.- Choice of stents and clinical outcomes in patients with CKD.- Revascularization strategies in CKD: PCI vs CABG.- Approach to revascularization in the potential kidney transplant recipient.- Nephrology consultative approach and risk stratification prior to revascularization in CKD.- Contrast Induced AKI: Epidemiology, risk stratification and prognosis.- Contrast induced AKI: Pathophysiological Mechanisms.- Prevention of Contrast Induced AKI: Summary of volume optimization strategies.- Prevention of Contrast induced AKI:  Contrast medium selection, adjuvant strategies andbest clinical practices.- Intra procedural and operator strategies for reduction of contrast induced AKI.- Effect of Percutaneous Ventricular Assist Devices on Renal Function.- Renal athero-embolic disease: An underdiagnosed entity.- Acute kidney injury with trans catheter aortic valve replacement.- Impact of kidney disease in catheter based mitral valve interventions.- Acute kidney injury with peripheral vascular interventions.- Renal Artery Stenosis:  State of the Art in Diagnosis and Management.- Renal Denervation: Physiology, scope and current evidence.- Economic impact of AKI and CKD in cardiac interventions.- Biomarkers in early risk stratification and management of post catheterization AKI.- Utilization of the cardio nephrology collaborative in the era of value based medicine.

Janani Rangaswami, MDClinical Associate ProfessorEinstein Medical Center / Thomas Jefferson UniversityDepartment of Medicine / NephrologyPhiladelphia, PA, USA  Edgar V. Lerma, MDClinical Professor of MedicineUIC/Advocate Christ Medical CenterDepartment of MedicineOak Lawn, IL, USA Peter A. McCullough, MD, MPHConsultant Cardiologists and Vice Chief of Internal MedicineBaylor University Medical CenterBaylor Heart and Vascular HospitalDepartment of Internal MedicineTexas A & M College of MedicineDivision of CardiologyDallas, TX, USA

• Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes.- Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions.- Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies.- Cardiovascular impact of Atherosclerotic Renovascular Disease.- Platelet Function testing and antiplatelet agent choice in CKD.- Choice of stents and clinical outcomes in patients with CKD.- Revascularization strategies in CKD: PCI vs CABG.- Approach to revascularization in the potential kidney transplant recipient.- Nephrology consultative approach and risk stratification prior to revascularization in CKD.- Contrast Induced AKI: Epidemiology, risk stratification and prognosis.- Contrast induced AKI: Pathophysiological Mechanisms.- Prevention of Contrast Induced AKI: Summary of volume optimization strategies.- Prevention of Contrast induced AKI:  Contrast medium selection, adjuvant strategies andbest clinical practices.- Intra procedural and operator strategies for reduction of contrast induced AKI.- Effect of Percutaneous Ventricular Assist Devices on Renal Function.- Renal athero-embolic disease: An underdiagnosed entity.- Acute kidney injury with trans catheter aortic valve replacement.- Impact of kidney disease in catheter based mitral valve interventions.- Acute kidney injury with peripheral vascular interventions.- Renal Artery Stenosis:  State of the Art in Diagnosis and Management.- Renal Denervation: Physiology, scope and current evidence.- Economic impact of AKI and CKD in cardiac interventions.- Biomarkers in early risk stratification and management of post catheterization AKI.- Utilization of the cardio nephrology collaborative in the era of value based medicine.

Janani Rangaswami, MDClinical Associate ProfessorEinstein Medical Center / Thomas Jefferson UniversityDepartment of Medicine / NephrologyPhiladelphia, PA, USA  Edgar V. Lerma, MDClinical Professor of MedicineUIC/Advocate Christ Medical CenterDepartment of MedicineOak Lawn, IL, USA Peter A. McCullough, MD, MPHConsultant Cardiologists and Vice Chief of Internal MedicineBaylor University Medical CenterBaylor Heart and Vascular HospitalDepartment of Internal MedicineTexas A & M College of MedicineDivision of CardiologyDallas, TX, USA

• Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes.- Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions.- Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies.- Cardiovascular impact of Atherosclerotic Renovascular Disease.- Platelet Function testing and antiplatelet agent choice in CKD.- Choice of stents and clinical outcomes in patients with CKD.- Revascularization strategies in CKD: PCI vs CABG.- Approach to revascularization in the potential kidney transplant recipient.- Nephrology consultative approach and risk stratification prior to revascularization in CKD.- Contrast Induced AKI: Epidemiology, risk stratification and prognosis.- Contrast induced AKI: Pathophysiological Mechanisms.- Prevention of Contrast Induced AKI: Summary of volume optimization strategies.- Prevention of Contrast induced AKI:  Contrast medium selection, adjuvant strategies andbest clinical practices.- Intra procedural and operator strategies for reduction of contrast induced AKI.- Effect of Percutaneous Ventricular Assist Devices on Renal Function.- Renal athero-embolic disease: An underdiagnosed entity.- Acute kidney injury with trans catheter aortic valve replacement.- Impact of kidney disease in catheter based mitral valve interventions.- Acute kidney injury with peripheral vascular interventions.- Renal Artery Stenosis:  State of the Art in Diagnosis and Management.- Renal Denervation: Physiology, scope and current evidence.- Economic impact of AKI and CKD in cardiac interventions.- Biomarkers in early risk stratification and management of post catheterization AKI.- Utilization of the cardio nephrology collaborative in the era of value based medicine.